三诺生物传感股份有限公司是一家致力于糖尿病全病程管理的高新技术上市公司。于2002年创立，总部位于中国湖南省长沙市，2012年在深交所上市。2016年，先后收购美国Trividia Health,Inc和美国PTS两家公司，进入全球血糖仪行业领先阵营。
目前，三诺在全国零售市场份额已达到58.5%，是中国零售市场第一，业务遍布全球135个国家和地区。因消费者信任及坚持为员工提供成长的平台，三诺生物在2018年、2019年连续两年获得中国优秀雇主奖，2020年获得 优选雇主奖 。在向国际化迈进的道路上，我们需要具有海外背景的高潜人才，经过加速培养体系，跨国轮岗，成为三诺未来的技术专家和国际化管理人才。
Sinocare Inc. is a high-tech listed company devoted to the whole course management of diabetes. Founded in 2002, headquartered in Changsha City, Hunan Province, China, and listed Ｏn the Shenzhen Stock Exchange in 2012. In 2016, Sinocare acquired Trividia Health, Inc and PTS successively, becoming the leading company in the global blood glucose meter industry.
At present, Sinocare's retail market share in the country has reached 58.5%, ranking first in China's retail market, and its business has covered 135 countries and regions all over the world.
Sinocare won the "China preferred employer award "in 2018 and 2019 for two consecutive years and "China Optimal Employer Award" in 2020 because of consumer’s trust and persistence in providing growth platform for employee
